Portfolio company
Kalgene
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops precision medicine therapeutics and companion diagnostics to treat Alzheimer's disease and various cancers for patients and clinical providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Korsana Biosciences
This biotechnology company develops brain-penetrant therapeutics for patients with neurodegenerative conditions such as Alzheimer's disease.
CaSRevolution
This biotechnology company develops therapies for Alzheimer's disease by creating molecules that target the calcium-sensing receptor to halt neurodegeneration.
AC Immune
This biopharmaceutical company develops therapeutic and diagnostic candidates for neurodegenerative diseases, providing precision medicine solutions to patients, healthcare providers, and pharmaceutical partners.
Tetraneuron
This company develops gene therapies to treat Alzheimer's and other neurodegenerative diseases for healthcare providers and patients.
Cajal Neuroscience
This biotechnology company develops drug discovery platforms and therapeutics for neurodegenerative diseases to assist healthcare providers and patients.
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
Rodin Therapeutics
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for neurodegenerative disorders including Alzheimer's and Parkinson's diseases for healthcare providers and patients.
